Question 1

What is Hemab Therapeutics Holdings, Inc. stock price today?

Accepted Answer

The current price of COAG is 28.50 USD — it has increased by 1.79% in the past 24 hours. Watch Hemab Therapeutics Holdings, Inc. stock price performance more closely on the chart.

Question 2

What is Hemab Therapeutics Holdings, Inc. stock ticker?

Accepted Answer

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Hemab Therapeutics Holdings, Inc. stocks are traded under the ticker COAG.

Question 3

Is Hemab Therapeutics Holdings, Inc. stock price growing?

Accepted Answer

COAG stock has risen by 8.37% compared to the previous week, the month change is a −7.68% fall, over the last year Hemab Therapeutics Holdings, Inc. has showed a −7.68% decrease.

Question 4

What is COAG stock forecast?

Accepted Answer

We've gathered analysts' opinions on Hemab Therapeutics Holdings, Inc. future price: according to them, COAG price has a max estimate of 50.00 USD and a min estimate of 36.00 USD. Watch COAG chart and read a more detailed Hemab Therapeutics Holdings, Inc. stock forecast: see what analysts think of Hemab Therapeutics Holdings, Inc. and suggest that you do with its stocks.

Question 5

What are Hemab Therapeutics Holdings, Inc. stock highest and lowest prices ever?

Accepted Answer

COAG reached its all-time high on May 4, 2026 with the price of 32.00 USD, and its all-time low was 23.00 USD and was reached on May 11, 2026. View more price dynamics on COAG chart. See other stocks reaching their highest and lowest prices.

Question 6

How volatile is COAG stock?

Accepted Answer

COAG stock is 7.88% volatile and has beta coefficient of −14.49. Track Hemab Therapeutics Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hemab Therapeutics Holdings, Inc. there?

Question 7

What is Hemab Therapeutics Holdings, Inc. market cap?

Accepted Answer

Today Hemab Therapeutics Holdings, Inc. has the market capitalization of 1.33 B, it has decreased by −4.64% over the last week.

Question 8

Does Hemab Therapeutics Holdings, Inc. release reports?

Accepted Answer

Yes, you can track Hemab Therapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.

Question 9

What is COAG net income for the last quarter?

Accepted Answer

COAG net income for the last quarter is −22.69 M USD, while the quarter before that showed −15.31 M USD of net income which accounts for 0.00% change. Track more Hemab Therapeutics Holdings, Inc. financial stats to get the full picture.

Question 10

Does Hemab Therapeutics Holdings, Inc. pay dividends?

Accepted Answer

No, COAG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Question 11

How many employees does Hemab Therapeutics Holdings, Inc. have?

Accepted Answer

As of May 31, 2026, the company has 72 employees. See our rating of the largest employees — is Hemab Therapeutics Holdings, Inc. on this list?

Question 12

How to buy Hemab Therapeutics Holdings, Inc. stocks?

Accepted Answer

Like other stocks, COAG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hemab Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.

Date	Open	High	Low	Close	Adj. Close	Change	Volume
2026-05-29	$27.70	$29.44	$27.29	$28.50	$28.50	+0.80	123,700
2026-05-28	$29.26	$29.89	$27.60	$28.00	$28.00	-1.26	133,000
2026-05-27	$28.00	$30.00	$27.66	$28.60	$28.60	+0.60	147,900
2026-05-26	$26.75	$28.00	$26.75	$27.84	$27.84	+1.09	270,900
2026-05-22	$26.30	$27.04	$25.21	$25.89	$25.89	-0.41	135,200
2026-05-21	$26.07	$27.81	$25.40	$26.30	$26.30	+0.23	193,400
2026-05-20	$24.21	$26.50	$24.21	$26.47	$26.47	+2.26	161,800
2026-05-19	$27.15	$27.43	$24.60	$25.44	$25.44	-1.71	132,600
2026-05-18	$27.62	$27.94	$25.42	$27.15	$27.15	-0.47	151,200
2026-05-15	$28.36	$29.22	$27.11	$28.07	$28.07	-0.29	118,300
2026-05-14	$28.43	$29.31	$27.30	$28.37	$28.37	-0.06	157,600
2026-05-13	$26.00	$28.65	$25.40	$28.56	$28.56	+2.56	209,700
2026-05-12	$24.63	$26.38	$24.53	$25.90	$25.90	+1.27	142,700
2026-05-11	$25.10	$25.31	$23.00	$25.00	$25.00	-0.10	239,300
2026-05-08	$25.74	$26.59	$24.55	$25.12	$25.12	-0.62	207,100
2026-05-07	$24.96	$26.00	$23.76	$25.74	$25.74	+0.78	202,100
2026-05-06	$25.25	$25.98	$23.48	$25.01	$25.01	-0.24	569,600
2026-05-05	$23.81	$25.50	$23.81	$25.00	$25.00	+1.19	461,200
2026-05-04	$30.87	$32.00	$24.94	$25.34	$25.34	-5.53	579,000
2026-05-01	$27.00	$36.61	$27.00	$34.00	$34.00	+7.00	4,113,600

Form	Filing Date	Document
10-Q	May 21, 2026	Quarterly Report
8-K	May 21, 2026	Current Report
SCHEDULE 13G	May 11, 2026	Filing
SCHEDULE 13D	May 11, 2026	Filing
8-K	May 11, 2026	Current Report
SCHEDULE 13G	May 8, 2026	Filing
8-K	May 4, 2026	Current Report
S-8	May 4, 2026	Securities to be offered to employees in employee benefit plans
424B4	May 1, 2026	Prospectus
EFFECT	Apr 30, 2026	Notice of Effectiveness

About

Hemab Therapeutics Holdings, Inc. Overview

Offer & Key Dates

Live Market Snapshot

Valuation & Multiples

Financial Health

Analyst Estimates

Risk Metrics

Earnings Calendar

Financial Highlights

Historical Data

SEC Filings

Company Info

Leadership

Hemab Therapeutics Holdings, Inc. IPO - FAQs

Hemab Therapeutics Holdings, Inc.